Chris Claxton, Vice President of Investor Relations and Corporate Communications at Horizon Discovery Group PLC (LON:HZD) talks to Proactive about the company entering into an agreement with an unnamed global molecular diagnostics provider to develop reference standards for non-invasive prenatal testing (NIPT).
Horizon Discovery Group inks 'significant' reference standards deal
Quick facts: Horizon Discovery Group PLC
Price: 191 GBX
Market Cap: £302.26 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Horizon Discovery Group PLC named herein, including the promotion by the Company of Horizon Discovery Group PLC in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE